FDA Needs More Time To Review GSK/Adolor’s Entereg
Adolor tells investors that FDA will not act on the postoperative ileus treatment in time to meet the May 10 PDUFA date.
Adolor tells investors that FDA will not act on the postoperative ileus treatment in time to meet the May 10 PDUFA date.